Target intelligence / Profile preview

Escherichia coli O75 antigen (O75)

Target
O75
Molecular classification
Other, Bacterial surface antigen, Lipopolysaccharide
01

Overview

The Escherichia coli O75 antigen is a specific O-polysaccharide component of the lipopolysaccharide (LPS) located on the outer membrane of certain Escherichia coli strains, particularly Extraintestinal Pathogenic E. coli (ExPEC) [1, 14]. It plays a vital role in bacterial virulence by contributing to the structural integrity of the cell envelope and protecting the bacterium from host immune mechanisms, such as serum-mediated lysis and phagocytosis [9, 14]. Serotype O75 is recognized as one of the most prevalent antigens associated with invasive E. coli disease (IED), including bacteremia and urosepsis, particularly in older adults and individuals with recurrent urinary tract infections [1, 5, 21]. Due to its clinical significance, the O75 antigen is a key target in the development of multivalent bioconjugate vaccines, such as ExPEC9V and ExPEC10V [2, 3, 5]. These vaccines are designed to stimulate the production of functional antibodies that facilitate the opsonophagocytic killing of the pathogen, thereby preventing severe systemic infections [2, 6]. The O75 antigen's structural diversity is a hallmark of E. coli serotyping and is critical for epidemiological tracking of pathogenic outbreaks [14]. Therapeutic strategies focusing on this antigen aim to provide broad protection against the diverse strains of ExPEC that utilize O75 for survival within the host [4, 8].

Other names
O75 polysaccharideE. coli O75 LPSO75 O-antigenECOO75Escherichia coli O75 O-antigen
02

Mechanism of action

Induction of antigen-specific functional antibodies (IgG) that promote opsonophagocytic killing (OPK) of the bacteria by host immune cells [2, 3, 9].

03

Biological functions

OtherCell wall organizationVirulenceImmune evasion
04

Disease associations

InfectionOther
05

Safety considerations

Injection site painErythemaPyrexiaMyalgiaPotential for endotoxicity
06

Interacting drugs

ExPEC9V (JNJ-78901563)

1 more in the full profile.

07

Biomarkers

Anti-O75 IgG antibody titerOpsonophagocytic activity (OPA) titerPresence of O75 serotype in clinical isolates

Beyond the preview

Go deeper on Escherichia coli O75 antigen (O75).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli O75 antigen (O75).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call